Read news as it happens
Create a Rediffmail account
Subscribe via RSS
After US, India to probe Ranbaxy's documents
After US, India to probe Ranbaxy’s documents SUSHMI DEY New Delhi, 22 May Health ministry tells DCGI to examine past dossiers, drug applications In what could be the beginning of fresh......
Drug makers seek out-of-court settlement in clinical trial cases
In order to keep pace with the government’s healthcare agenda, the pharmaceutical sector wants research work to go on, at any cost. In a letter to health minister Harsh Vardhan, the Indian......
Why is Novartis likely to lose Tiamulin drug licence?
Swiss drug maker Novartis is likely to face legal action for allegedly faking documents to seek registration of its veterinary product Tiamulin Hydrogen Fumarate (80 per cent granules) in India.......
Ranbaxy whistle-blower to talk on quality of Made-in-India drugs
The concerns surrounding drug manufacturing practices in India appear to have reached foreign shores, beyond the international regulators’ domain. Ranbaxy whistle-blower Dinesh Thakur,......
Keep us in loop before any FDA swoop, India tells US
Inspections only in domestic authorities’ presence, visiting US drug regulator told Taking a tough stand on the ongoing regulatory issues faced by the domestic pharmaceutical industry because......
Top Coverage News
Coming to India and making
Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
India, through the eye of a camera
Commonwealth Games - 2014
The defence coverage of Rediff.com
The ISIS war in Iraq
Office email App
© 2015 Rediff.com
India Abroad weekly